Despite excise tax, Medtech jobs steady and even rising – but it’s still...
Looks like employment’s steady globally in the medical device sector, despite the doom-and-gloom provocations from those […]
View ArticleReport: Big medtech’s ranks are swelling thanks to M&A
A new medtech job growth report from EP Vantage suggests the level of consolidation and spinout activity we saw in 2014 could be repeated this year.
View ArticleClik here to view.
Biotech venture performance in 2015: Huge financings, few rounds
Biotech venture rounds favored “the lucky few” in 2015, as more cash was poured into a smaller number of upper echelon life sciences companies.
View ArticleClik here to view.
Here’s 2017 biopharma sales projections, but Trump might have other plans
The unpredictable president-elect has made industry forecasting a much tougher job. But the show must go on. Here are some highlights from Evaluate Pharma’s new 2017 biopharma report; the winners, the...
View ArticleClik here to view.
In an era of mega-rounds, Roivant Sciences still makes a splash with $1.1B haul
Billion-dollar private venture capital rounds are apparently now a “thing.” Roivant sealed the deal on Wednesday, following a multi-year trend towards bigger investment rounds in the life sciences.
View Article